NCT02051946View on ClinicalTrials.gov

Novel Drug Delivery Technique Via Retroject Device

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Glaucoma
Interventions
DEVICE

Retroject Device

DRUG

ethacrynic acid injection

DRUG

balanced salt solution

Trial Locations (1)

27710

Duke University Eye Center, Durham

All Listed Sponsors
lead

Molly Walsh

OTHER

NCT02051946 - Novel Drug Delivery Technique Via Retroject Device | Biotech Hunter | Biotech Hunter